Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data.

Anthia PapazoglouRené HöhnMegir SchawkatChristoph TappeinerMilko IlievKonstantin GugletaGiulia SalettaAndrea WiencierzBarbara WagelsMargarita G TodorovaIwona KrzyzanowskaMarc Töteberg-HarmsMarkus Tschopp

Published in: Ophthalmology and therapy (2024)

The XEN45 Gel Stent successfully reduced IOP and the number of antiglaucoma drugs in most patients at 2 years postoperatively.

Keyphrases

electronic health record
hyaluronic acid
double blind
deep learning
artificial intelligence